Polyrizon files European patent application for drug delivery platform

Go back to Polyrizon files European patent application for drug delivery platform

Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platform

April 27, 2026 9:28 AM EDT

Raanana, Israel, April 27, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the Company or Polyrizon), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a divisional patent application with the Europe Patent Office for its Trap & Target (T&T) platform technology. This application focuses exclusively on protecting the Companys advanced intranasal drug delivery system, which is designed to enhance the effectiveness of medications by increasing their residence time and ensuring close contact with mucosal tissues and aligns with the Companys recently announced U.S. patent application which... More